HomeTSHA • NASDAQ
add
Taysha Gene Therapies Inc
Previous close
$4.47
Day range
$4.30 - $4.61
Year range
$1.05 - $6.02
Market cap
1.24B USD
Avg Volume
2.85M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 5.48M | 171.27% |
Operating expense | 33.78M | 53.89% |
Net income | -27.85M | -48.26% |
Net profit margin | -507.77 | 45.34% |
Earnings per share | -0.07 | — |
EBITDA | -28.00M | -42.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 319.77M | 129.99% |
Total assets | 343.32M | 114.09% |
Total liabilities | 96.38M | 8.49% |
Total equity | 246.94M | — |
Shares outstanding | 287.27M | — |
Price to book | 5.14 | — |
Return on assets | -21.44% | — |
Return on capital | -23.38% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -27.85M | -48.26% |
Cash from operations | -26.72M | -45.96% |
Cash from investing | -247.00K | -2,000.00% |
Cash from financing | 49.56M | 13,981.23% |
Net change in cash | 22.59M | 221.10% |
Free cash flow | -18.67M | -64.51% |
About
Founded
2019
Headquarters
Website
Employees
99
